// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

THE ROLE OF HEALTHCARE PROVIDERS IN OUR OVERPOPULATION CRISIS

Jan Gregus - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

WHAT ARE THE DRIVERS AND CONSEQUENCES OF MATERNAL MENTAL HEALTH DISORDERS IN BANGLADESH?

Maisha Fatima Syed - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ADAPTING RCOG CLINICAL GUIDANCE TO LOCAL SETTINGS

Nia Sheppard - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ARE BAME PREGNANT WOMEN AT AN INCREASED RISK OF CONTRACTING COVID-19? A SYSTEMATIC REVIEW AND META-ANALYSIS

Emily Marshall - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

ASK THE EXPERTS: WORKING WITH A MULTIDISCIPLINARY INTERNATIONAL ADVISORY GROUP TO ADVANCE FAMILY PLANNING RESEARCH KNOWLEDGE AND EVIDENCE USE

Áine Aventin - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

VULVAL MISNOMERS: IMPACT ON DIAGNOSIS: VARIATION BETWEEN PERCEIVED AND ACTUAL IMPACT

Tolu O. Adedipe - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

CASE SERIES OF COVID-19 INFECTED PREGNANT WOMEN: TRIAL OF LABOUR AND CLINICAL CHARACTERISTICS

Kiichiro Furuya - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

MATERNAL (POSTPARTUM) AND POSTNATAL OUTCOME OF PREGNANT PATIENTS IN THEIR LAST TRIMESTER WITH COVID-19 IN HOSPITAL - SYSTEMATIC REVIEW

Justin Rui Zhe Soon - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

MATERNAL DEATH: LEARNING FROM MATERNAL DEATH INVESTIGATIONS DURING THE FIRST WAVE OF THE COVID-19 PANDEMIC

Louise M. Page - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

EVALUATION OF CASES OF STILLBIRTH AND NEONATAL DEATH IN TWIN PREGNANCIES IN A TERTIARY CENTRE IN NORTHERN ENGLAND OVER 5 YEARS

Holly J. Craig - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

IMPROVING ANTENATAL CARE THROUGH INTRODUCTION OF QUALITY POINT-OF-CARE SERVICES BY FRONT-LINE HEALTH PROVIDERS IN INDIA: EXPERIENCE FROM RAJASTHAN

Saswati Das - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A NON-INFERIORITY ANALYSIS OF HAEMOGLOBIN LEVELS IN POST-PARTUM IUD USERS IN BANGLADESH

Suzanna Bright - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

TRAINING THROUGH FIGO

Anita Makins - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

FIGO/WHO COLLABORATION TO DISSEMINATE FAMILY PLANNING GUIDELINES AT A GLOBAL LEVEL - MONITORING AND EVALUATION

Neda Taghinejadi - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

RAPID FETAL EXOME SEQUENCING FOR THE DIAGNOSIS OF MONOGENIC CONDITIONS IN FETUSES WITH STRUCTURAL ABNORMALITIES

Lyn Chitty - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

POSTERIOR COMPARTMENT REPAIR: WHEN AND HOW

Manjula Annappa - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

FIGO NUTRITION CHECKLIST – TIME TO EXTEND ITS USE

Mark Hanson - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

MEASUREMENTS OF QUALITY IN OBSTETRIC CARE

Sir Arulkumaran Sabaratnam - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

BRINGING SRHR RELIEF IN SITUATIONS OF CRISIS AND CONFLICT

Julie Taft - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

IDENTIFICATION OF THOSE AT-RISK FOR PFD AND THEIR COUNSELLING

Bob Freeman - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Pelvic floor dysfunction

N/A

Copyright © 2026. QuantiNova All rights reserved